As long they maintain a good quality low risk balance sheet, making nice profit in a down turn market, I would not ask for more. I expect their NTA value should be above $1.7 with this transaction.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025